Skip to content

ACDS

by Isopure, Corp.

510(k) K120005

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

2 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK120005 Date29 Mar 2012ClearedStatusActive

Official records

From the FDA record

Received by the FDA
3 Jan 2012
FDA decision
29 Mar 2012 (Substantially Equivalent)
FDA review time
86 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K120005 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

2 recalls · FDA

    • Terminated Z-1739-2022 FDA Class II initiated 26 Jul 2022

    Acidified Concentrate Distribution System potential electrical safety hazard may result in electric shock, arching

    • Terminated Z-0821-2020 FDA Class II initiated 19 Apr 2019

    There is a potential for an uneven plastic encapsulation of the magnet ring during the molding process and partial axial displacement. This issue could cause uneven wear during use, cause exposure of the magnet to solution, and thereby result in corrosion and the presence of iron.

Timeline

3 dated events

  1. Cleared FDA 510(k) K120005
  2. Recall initiated FDA recalls Z-0821-2020
  3. Recall initiated FDA recalls Z-1739-2022

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
KPO
Device class
Class II
Regulation
21 CFR Part 876.5820
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The ACDS is a Dialysate Concentrate for Hemodialysis (Liquid or Powder) designed for automated storage and distribution of acidified concentrate in clinical settings. It ensures precise dosing and delivery of hemodialysis fluids by integrating storage tanks, pumps, and control units to maintain sterile and consistent concentrate distribution for renal therapy.

This system is supplied as a reusable, non-sterile medical device intended for use in hemodialysis facilities. It adheres to AAMI National Standards for hemodialysis and operates within FDA 510(k) clearance (K120005) under regulation 876.5820. The device is engineered for clinical environments, with components including acid concentrate tanks, pumps, and monitoring alerts for low-tank levels, ensuring reliable fluid management for renal treatment protocols.

Devices cleared under K120005

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K120005
UDI-DISize and differences
Acidified Concentrate Distribution and Storage (ACDS) System MD704262
Isopure, Corp.
MD70426200852456007092 —On the market

Similar devices

Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).

Other devices from Isopure, Corp.

See all devices from Isopure, Corp. →